The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Novel Insulin-Independent Mechanism of Action Hits Triple Targets in Type 2 Diabetes

Barcelona, Spain / November 8-11, 2012

Barcelona - Management of type 2 diabetes mellitus (T2DM) implies more than achieving good glycemic control as most patients have comorbid conditions including high blood pressure (BP) and dyslipidemia. Most are overweight or obese as well....

PRIORITY PRESS - 64th Annual Meeting of the National Hemophilia Foundation

Hemophilia Management: Evaluating RICE and Factor Replacement Therapy with Longer Half-life

Orlando, Florida / November 8-10, 2012

Orlando - Conservative therapy in the management of joint and muscle bleeding in patients with hemophilia has consisted primarily of interventions known collectively as RICE: rest, ice, compression and elevation. A critical assessment of...

PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)

Options for Iron Correction and Erythropoiesis Stimulation: Better Benefit:Risk Through Individualized Therapy

San Diego, California / October 30 - November 4, 2012

San Diego - More sophisticated strategies for the treatment of anemia in patients with chronic kidney disease (CKD), including those on dialysis, are being driven by new options for replenishing iron and stimulating erythropoiesis. The...

PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)

Halting Threat of Kidney Failure by Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies

San Diego, California / October 30-November 4, 2012

San Diego - Two-year results with a targeted monoclonal antibody (MAb) against the complement protein C5 demonstrated that the kidney damage caused by atypical hemolytic uremic syndrome (aHUS) and shiga-toxin producing Escherichia coli HUS...

PRIORITY PRESS - 65th Annual Meeting of the Canadian Cardiovascular Society

Effective Event Reduction in the Era of New Oral Anticoagulants: Pursuing Options

Toronto, Ontario / October 27-31, 2012

Toronto - After 50 years of warfarin use for stroke prevention in atrial fibrillation (AF), there are now 3 new oral anticoagulants equal to, or better than warfarin for stroke prevention. Importantly, they are safer than warfarin in terms...

PRIORITY PRESS - 2012 Canadian Hypertension Congress

Optimal Control of Hypertension: From Lifestyle Modifications to Fixed-Dose Combinations

Toronto, Ontario / October 25-28, 2012

Toronto - Over 1000 patients in Canada are diagnosed with hypertension each day. Best treatment plan depends on factors including severity of high blood pressure (BP), age, comorbidities, as well as, patient and physician preference. Common...

PRIORITY PRESS - 2012 Canadian Hypertension Congress

A Template for Improved Blood Pressure Control and Better Adherence: Integrating Third Generation b-blockers and Single-pill Multiple Mechanism Combinations

Toronto, Ontario / October 25-28, 2012

Toronto - For the prevention, diagnosis and treatment of high blood pressure (BP), the Canadian Hypertension Education Program (CHEP) guidelines provide a template against which physicians can tailor antihypertensive regimens according to...

MEDICAL FRONTIERS - 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Expansion of MS Therapies: Multicentre Phase III Trials of First-Line Oral Agents

Lyon, France / October 10-13, 2012

Lyon - Oral therapies for the control of multiple sclerosis (MS) are poised to proliferate, based on data presented at the 2012 ECTRIMS. Phase III trials have associated several agents with high rates of efficacy both in regard to the risk...

MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting

Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus

Vancouver, BC / October 10-13, 2012

Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...

PAGE 19 OF 123   ... 11 12 13 14 15 16 17 18 19 20 ...